Emblation logo — Medical microwave technology in Oncology, Dermatology, and P...

Emblation

Medical microwave technology in Oncology, Dermatology, and Podiatry

Founded 2007 United Kingdom Alloa, United Kingdom 50 employees Venture round Health Care, Medical Devices

General Information

Company Name Emblation
Founded Year 2007
Location United Kingdom Alloa, United Kingdom
Employees 50
Industries Health Care, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Emblation. To contact Emblation, visit emblation.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Emblation

Emblation, a global leader in medical microwave technology, focuses on revolutionary innovation in the treatment of HPV infections, dermatology, cardiology, and oncology. Launched in 2008 and headquartered in United Kingdom, the company has gained recognition for its award-winning treatment Swift® in Oncology, Dermatology, and Podiatry. The company's Swift® treatment has expanded to the UK, Canada, Australia, and the USA, experiencing rapid growth in the field of Podiatry. Emblation also offers its Rapid Product Development Service through www.emblationmicrowave.com, collaborating with global healthcare leaders to utilize its patented microwave generator platform technology, enabling partners to benefit from a swift product development process and a streamlined regulatory submission. Notably, the company secured a recent Venture Round investment on 24 May 2021, with Apposite Capital as the investor. Emblation's commitment to innovation and growth positions it as a promising prospect in the Health Care industry.

Taxonomy: medical microwave technology, oncology treatment, dermatology treatment, podiatry treatment, HPV infections, Swift, microwave generator platform technology, rapid product development, clinical applications, regulatory submission, global leader, innovation, agile team

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
Apposite Capital
24 May 2021

Emblation Alternatives & Competitors

View All Alternatives
Emblation vs

Introducing the next generation microwave ablation device for cancer treatment

Series A
10 employees
Health Care, Medical Devices
Emblation vs

Trusted business partner for global MedTech companies. Your Success is our Future..!!

9 employees
Health Care, Medical Devices
Emblation vs

Bringing Groundbreaking Technologies to the World

4 employees
Biotechnology, Health Care

FAQ About Emblation

Medical microwave technology in Oncology, Dermatology, and Podiatry
Emblation was founded in 2007.
Emblation is headquartered in Alloa, United Kingdom.
Emblation operates in Health Care and Medical Devices. Its work centres on medical microwave technology, oncology treatment, dermatology treatment and podiatry treatment.
Emblation has approximately 50 employees.
Emblation has completed 1 funding round. The latest funding stage is Venture round.
Top alternatives and competitors to Emblation include HEPTA Medical, 8C Healthcare, Ascendant Biotech Corporation, Vascular Flow Technologies Ltd, VIVE-MedTech GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Emblation and HEPTA Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Emblation, https://bouncewatch.com/company/emblation, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes